AP
APOC3-mediated dyslipidemia in kidney disease and atherosclerosis in diabetes
Jenny Kanter
NIDDK
AS
ASCEND: A Trial of Sertraline vs. CBT for End-Stage Renal Disease Patients with Depression
Rajnish Mehrotra
PCORI
AS
ASSESS-AKI: Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury
Jonathan Himmelfarb
NIDDK
Jonathan Himmelfarb, MD
Be
Best Case Worst Case: Effective Communication between Kidney Specialists and Their Patients
Daniel Lam
NIH
CA
CANDY CANE: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease – Changing Glucose Management
Ian de Boer
ADA
CA
CANDY: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease
Ian de Boer
ADA
CL
CLEAR: Clearance of 25-hydroxyvitamin D in chronic kidney disease
Ian de Boer
NIDDK
CO
CONCORD: Combination of Novel Therapies for CKD Comorbid Depression
Rajnish Mehrotra
NIDDK
Co
CoNR: Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK
ES
ESTEEM: Exercise Study Testing Enhanced Energetics of Muscle Mitochondria in Chronic Kidney Disease
Baback Roshanravan
NIDDK
Baback Roshanravan, MD
GL
GLUTE: Randomized Trial of Glutamine in Chronic Kidney Disease
Jonathan Himmelfarb
NIDDK / NY Medical College
Jonathan Himmelfarb, MD
Ki
Kidney Tubular Functions in Type 1 Diabetes
Ian de Boer
NIDDK
ME
MEND: Muscle Mitochondria Energetics in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK
PE
PERLage: Preventing Early Renal Loss in Diabetes
Ian de Boer
Joslin Diabetes Center (Flow…
RE
REMODEL-T1D
Ian de Boer
Breakthrough T1D
